These final results, together with a previous report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,two aid the principle of focusing on ACKR3 as a unique strategy to modulate the opioid program, which could open new therapeutic avenues for opioid-linked Conditions. When you have questions https://danielr816trx6.blogs100.com/profile